S&P 500   3,638.35 (+0.24%)
DOW   29,910.37 (+0.13%)
QQQ   299.01 (+0.92%)
AAPL   116.59 (+0.48%)
MSFT   215.23 (+0.64%)
FB   277.81 (+0.81%)
GOOGL   1,787.02 (+1.30%)
AMZN   3,195.34 (+0.32%)
TSLA   585.76 (+2.05%)
NVDA   530.45 (+0.20%)
BABA   276.48 (-0.45%)
CGC   29.00 (+7.93%)
GE   10.40 (-0.95%)
MU   64.23 (+1.26%)
AMD   87.19 (+0.55%)
T   29.03 (+0.14%)
NIO   54.00 (+0.58%)
F   9.09 (+0.11%)
ACB   10.47 (+20.21%)
NFLX   491.36 (+1.31%)
GILD   60.03 (+0.89%)
BA   216.50 (-0.51%)
DIS   147.13 (-1.31%)
S&P 500   3,638.35 (+0.24%)
DOW   29,910.37 (+0.13%)
QQQ   299.01 (+0.92%)
AAPL   116.59 (+0.48%)
MSFT   215.23 (+0.64%)
FB   277.81 (+0.81%)
GOOGL   1,787.02 (+1.30%)
AMZN   3,195.34 (+0.32%)
TSLA   585.76 (+2.05%)
NVDA   530.45 (+0.20%)
BABA   276.48 (-0.45%)
CGC   29.00 (+7.93%)
GE   10.40 (-0.95%)
MU   64.23 (+1.26%)
AMD   87.19 (+0.55%)
T   29.03 (+0.14%)
NIO   54.00 (+0.58%)
F   9.09 (+0.11%)
ACB   10.47 (+20.21%)
NFLX   491.36 (+1.31%)
GILD   60.03 (+0.89%)
BA   216.50 (-0.51%)
DIS   147.13 (-1.31%)
S&P 500   3,638.35 (+0.24%)
DOW   29,910.37 (+0.13%)
QQQ   299.01 (+0.92%)
AAPL   116.59 (+0.48%)
MSFT   215.23 (+0.64%)
FB   277.81 (+0.81%)
GOOGL   1,787.02 (+1.30%)
AMZN   3,195.34 (+0.32%)
TSLA   585.76 (+2.05%)
NVDA   530.45 (+0.20%)
BABA   276.48 (-0.45%)
CGC   29.00 (+7.93%)
GE   10.40 (-0.95%)
MU   64.23 (+1.26%)
AMD   87.19 (+0.55%)
T   29.03 (+0.14%)
NIO   54.00 (+0.58%)
F   9.09 (+0.11%)
ACB   10.47 (+20.21%)
NFLX   491.36 (+1.31%)
GILD   60.03 (+0.89%)
BA   216.50 (-0.51%)
DIS   147.13 (-1.31%)
S&P 500   3,638.35 (+0.24%)
DOW   29,910.37 (+0.13%)
QQQ   299.01 (+0.92%)
AAPL   116.59 (+0.48%)
MSFT   215.23 (+0.64%)
FB   277.81 (+0.81%)
GOOGL   1,787.02 (+1.30%)
AMZN   3,195.34 (+0.32%)
TSLA   585.76 (+2.05%)
NVDA   530.45 (+0.20%)
BABA   276.48 (-0.45%)
CGC   29.00 (+7.93%)
GE   10.40 (-0.95%)
MU   64.23 (+1.26%)
AMD   87.19 (+0.55%)
T   29.03 (+0.14%)
NIO   54.00 (+0.58%)
F   9.09 (+0.11%)
ACB   10.47 (+20.21%)
NFLX   491.36 (+1.31%)
GILD   60.03 (+0.89%)
BA   216.50 (-0.51%)
DIS   147.13 (-1.31%)
Log in
ASX:IBX

Imagion Biosystems Limited (IBX.AX) Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range
A$0.02
MA: A$0.02
A$0.02
52-Week Range N/A
Volume10.77 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Imagion Biosystems Limited provides medical imaging technologies to detect and eliminate cancer. It has activities in nanotechnology; biotechnology; cancer diagnostics; and superparamagnetic relaxometry. The company engages in the research and development of its MagSense system to detect HER2 breast cancers. It uses MagSense technology that is based on superparamagnetic relaxometry for early cancer detection, cancer staging, and therapeutic monitoring. The company was founded in 1996 and is based in San Diego, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.56 out of 5 stars


Industry, Sector and Symbol

Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone855-564-5264
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.44 million
Book ValueA$0.01 per share

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

Receive IBX News and Ratings via Email

Sign-up to receive the latest news and ratings for IBX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Imagion Biosystems Limited (IBX.AX) (ASX:IBX) Frequently Asked Questions

What stocks does MarketBeat like better than Imagion Biosystems Limited (IBX.AX)?

Wall Street analysts have given Imagion Biosystems Limited (IBX.AX) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Imagion Biosystems Limited (IBX.AX) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Imagion Biosystems Limited (IBX.AX)'s key competitors?

What other stocks do shareholders of Imagion Biosystems Limited (IBX.AX) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Imagion Biosystems Limited (IBX.AX) investors own include Arcadia Biosciences (RKDA), (PYX), Paradigm Biopharmaceuticals Limited (PAR.AX) (PAR), Alibaba Group (BABA) and Amani Gold Limited (ANL.AX) (ANL).

Who are Imagion Biosystems Limited (IBX.AX)'s key executives?

Imagion Biosystems Limited (IBX.AX)'s management team includes the following people:
  • Mr. Robert Romeo Proulx, Pres & CEO (Age 62, Pay $399.44k)
  • Ms. Jovanka Naumoska, Company Sec. & Non Exec. Director
  • Dr. Marie Zhang, Vice-Pres of Research & Pre- Clinical Dev

What is Imagion Biosystems Limited (IBX.AX)'s stock symbol?

Imagion Biosystems Limited (IBX.AX) trades on the ASX under the ticker symbol "IBX."

How big of a company is Imagion Biosystems Limited (IBX.AX)?

Imagion Biosystems Limited (IBX.AX) has a market capitalization of $0.00 and generates $2.44 million in revenue each year.

What is Imagion Biosystems Limited (IBX.AX)'s official website?

The official website for Imagion Biosystems Limited (IBX.AX) is www.imagionbiosystems.com.

How can I contact Imagion Biosystems Limited (IBX.AX)?

The company can be reached via phone at 855-564-5264.

This page was last updated on 11/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.